. Brucellosis is widespread in many animal hosts in Latin America (5) and thus of interest in white-tailed deer. Another major zoonosis, sometimes linked to raw deer meat consumption, is hepatitis E, which is caused by genotypes of hepatitis E virus (HEV) (6) . HEV is increasingly prevalent in red deer (Cervus elaphus) (7), but its prevalence in white-tailed deer is unknown.
The objective of this study was to determine the prevalence of zoonotic pathogens in white-tailed deer in northern Mexico. This study was conducted under a scientifi c collecting permit issued by the Mexican Division of Animal and Wildlife Health and on 8 ranches in 3 states in northern Mexico (≈26-28°N, 99-100°W).
Serum samples (n = 347) were collected during 2004-2009 in a cross-sectional survey for antibodies against HEV, Brucella spp., and mycobacteria. Deer were opportunistically sampled during live-capture operations as described by Cantú et al. (8) . Bleeding was performed by using jugular venipuncture and vacuum tubes without anticoagulant. Samples were allowed to clot and centrifuged to collect serum that was stored at −20°C.
Serum samples were tested for IgG against HEV by ELISA as described (7) . Serum samples were also tested for antibodies against Brucella spp. by using a commercial ELISA (Ingezim Brucella Compac 2.0 Ingenasa, Madrid, Spain), according to the manufacturer's instructions. Detection of antibodies cross-reacting with 2 widely used mycobacterial antigens, bovine purifi ed protein derivative (PPD) and paratuberculosis protoplasmatic antigen 3 (PPA3), was conducted as described (9) . The sensitivity and specifi city of this assay have not been established for white-tailed deer, but it has been used in seroprevalence studies of wild boar and fallow deer (9, 10) .
Insuffi cient volumes of serum samples prevented testing for antibodies against all pathogens (Table) . Limited serum volume and lack of other (organ) samples also precluded additional analyses to verify presence of pathogens.
Prevalence was 62.7% (95% CI 54%-70%) for antibodies against HEV, 0.4% (95% CI 0%-2%) for antibodies against Brucella spp., 8.9% (95% CI 6%-13%) for antibodies against bovine PPD, and 2.6% (95% CI 1%-5%) for antibodies against PPA3 (Table) . Antibody responses to bovine PPD were detected in deer from at 6 of 8 sampling sites; in deer from 3 of these sites, antibodies were also detected against PPA3 antigen. Seroprevalence against bovine PPD was higher than that against PPA3 (χ 2 10.9, df 1, p<0.01).
This cross-sectional survey of white-tailed deer in northern Mexico detected antibodies to several pathogens relevant to public and animal health. High prevalence of antibodies against HEV and frequent detection of antibodies against mycobacterial antigens are public health concerns. Prevalence of antibodies against HEV were 3× higher than that reported for red deer in Europe (7). This result suggests wide circulation of HEV in the study region and warrants further research, including detection and sequencing of virus RNA. Low Brucella spp. antibody prevalence confi rms results of a study in this region (8) .
Antibody responses to bovine PPD were detected in serum samples from deer from most sampling sites, occasionally in the absence of antibodies against PPA3. These results, and a recent report of an M. bovis-positive white-tailed deer from this region (2) , suggest that these deer may be contracting M. bovis in northern Mexico. If one considers that white-tailed deer are M. bovis reservoirs in other parts of North America and that risk factors such as supplemental feeding are present in northern Mexico, there is a high risk for pathogen transmission to animals and humans (1) . White-tailed deer are probably exposed to several pathogens that are relevant to animal health in northern Mexico.
Although this cross-sectional survey provided only an indication of pathogen prevalence in the study populations, high antibody prevalence to HEV and mycobacterial antigens requires antigen-targeted surveillance. Risks associated with pathogen translocation by white-tailed deer are also relevant to neighboring states in Mexico and the United States. 
KIs Virus and Blood Donors, France
To the Editor: KIs-V is a new putative virus identifi ed recently in the blood of persons in Japan (1). First partial sequence of KIs-V was characterized unexpectedly, when PCR primers were used that were directed primarily to the consensus domain of helicase of positivestranded RNA viruses. Extensive physicochemical and molecular analysis suggested that KIs-V is an enveloped virus with a circular, double-stranded DNA genome of ≈9,500 bp (prototype isolate: GenBank accession no. AB550431); its genetic diversity is presumed to be extremely low because the 4 complete genomes already characterized in Japan harbor strict identical sequences. The 13 potential genes identifi ed by in silico analysis exhibit an overall low sequence homology to other known viral proteins (1) . Until now, KIs-V epidemiologic data have been related only to the original study in which the authors analyzed plasma samples from 516 blood donors categorized into 4 groups by alanine aminotransferase (ALT) level (either <60 IU/L or >60 IU/L) and the presence or absence of hepatitis E virus (HEV) antibodies. As a result, KIs-V DNA was detectable at elevated prevalence in the high ALT level/HEV antibody-positive group (36%, n = 100); viral loads, checked for a few samples, ranged from 10 6 to 10 8 copies/mL. KIs-V DNA also was identifi ed in HEV antibody-negative samples, with low or high ALT level (≈0.8%, n = 120, and 1%, n = 100, respectively) (1).
To gain insights about the potential presence of this virus in the blood of persons in France, we investigated KIs-V DNA in the plasma of 576 healthy blood donors (mean age 40 years; 306 men; men:women 1:1.13). Blood samples were collected in vacuum tubes (Vacutainer, SST, Becton Dickinson, Meylan, France) and centrifuged, and plasma aliquots were stored at −80°C until use. Nucleic acids were extracted from 1-mL plasma volumes (MagNA Pure LC, Roche Diagnostics, Meylan, France) (2) and tested for KIs-V DNA by using the same nested PCR system for screening Japanese blood donors (1) . Briefl y, one tenth (5 μL) of extracted nucleic acids were fi rst amplifi ed by using primers 101-C (5′-CAACACCGCA ATCACAAAGT-3′) and N101-B (5′-AACATTGAAACGTCATGT CC-3′) (0.8 μM each) in a 50-μL mix containing deoxynucleotide triphosphates (0.2 mM each) (Roche) and 2 U Taq DNA polymerase (Invitrogen, Cergy Pontoise, France) with its corresponding buffer. One microliter of the amplifi cation mixture was subsequently used in a secondround PCR with primers KS-2 (5′ -CTCGTCCTCGTCGTCATC GTA-3′) and N101-D (5′-CA T T T G C T C C C G C T G G A G AT G -3′) under the same conditions as above. The amplifi cation conditions for fi rst-
